NASDAQ:CALA

Calithera Biosciences Stock Predictions

Healthcare > Biotechnology

Buy CALA

*Your capital is at risk

$0.0002

+0 (+0%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

CALA Prediction Chart

CALA Predictions History

Latest community submissions for CALA.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
JS Pro	Aug 8, 2017	$15.00 -94.86%	$14.60	X	97.30%	0
JuanC Villegas Pro	Aug 8, 2017	$15.18 -94.80%	$14.60	X	96.00%	0
AJR	Dec 22, 2016	$3.80 -94.57%	$3.50	X	91.40%	0
JS Pro	Dec 22, 2016	$3.55 -94.93%	$3.50	V	98.60%	1
Alexander.Lemus.1952	Dec 22, 2016	$3.55 -94.93%	$3.50	X	98.60%	1

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for CALA with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT CALITHERA BIOSCIENCES

Calithera Biosciences, Inc., a clinical-stage bio-pharmaceutical company, focuses on the discovery and development of small molecule compounds for tumor metabolism and tumor immunology targets for the treatment of cancer in the United States. The company offers INCB001158, an orally bioavailable arginase inhibitor of arginase that is in Phase 1/2 clinical trial for the treatment of hematology and oncology. It is developing CB-280, an oral arginas...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by